Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-06-03FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Mesalamine by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease [Phase 2]
Phase 2 trial evaluating filgotinib for fistulizing Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) [Phase 3]
Phase 3 trial of ontamalimab as maintenance treatment in moderate-to-severe Crohn's disease was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT) [Phase 2]
Phase 2 trial on fecal microbiota therapy (FMT) to prevent recurrence of Crohn's disease; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission [Phase 4]
A Phase 4 clinical trial update reports on discontinuing infliximab therapy in Crohn's disease patients who are in sustained complete remiss…
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease [Phase 2, Phase 3]
Clinical trial update comparing exclusion diet to corticosteroids in active Crohn's disease across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease [Phase 2]
Phase 2 trial of mirikizumab in active Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-21Clinical Trial Update: To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
Clinical trial update for Remsima in Crohn's disease and ulcerative colitis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease [Phase 2]
Phase 2 safety and efficacy study of JNJ-64304500 in moderately to severely active Crohn's disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease [Phase 2]
Phase 2 pilot trial evaluating fundamental modification of the gut microbiota for refractory Crohn's disease has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year [Phase 3]
A Phase 3 trial compares the safety and efficacy of adalimumab versus ustekinumab over one year in Crohn's disease; results have been posted…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 trial update for brodalumab in adults with moderate to severe Crohn's disease has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Long-term Safety Study of Brodalumab in Adults With Crohn's Disease [Phase 2]
A Phase 2 long-term safety study of brodalumab in adults with Crohn's disease was terminated; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease [Phase 2]
A Phase 2 trial evaluating efficacy, safety, and tolerability of V565 in Crohn's disease has completed with results posted.
-
FDA approval · 2021-12-17FDA Approved: YUSIMRY — Original Application (Coherus BioSciences Inc)
FDA approved YUSIMRY (adalimumab-aqvh) from Coherus BioSciences in an original biologics license application, likely as a biosimilar to adal…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Induction of Clinical Response Using Rifaximin in Crohn's Disease [Phase 2]
Phase 2 clinical trial evaluating rifaximin for induction of clinical response in Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Multicenter Trial For Patients With Acute Crohn's Disease [Phase 2]
A multicenter Phase 2 trial evaluating a treatment for acute Crohn's disease has been completed.
-
FDA approval · 2021-12-06FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Mesalamine from Actavis Pharma, Inc. (generic Mesalamine).
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 dose-ranging study of BMS-945429 in moderate to severe Crohn's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) [Phase 2]
Phase 2 trial assessing safety and effectiveness of the Live Zoster Vaccine in patients using anti-TNF therapy for inflammatory diseases, wi…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy [Phase 4]
Phase 4 trial results on an enhanced algorithm for Crohn's disease treatment using early combination therapy.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Ultrasound Evaluation of Crohn's Disease [Phase 4]
Phase 4 clinical trial evaluating ultrasound for Crohn's disease has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain [Phase 2]
Phase 2 trial update on tolerability, pharmacokinetics, and efficacy of APD371 in Crohn's disease patients with abdominal pain; results post…
-
FDA approval · 2021-11-01FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine EN-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.